Stefan Kaluzny

Stefan Kaluzny is the co-founder and Managing Director of Sycamore Partners, a New York-based private equity firm he launched in 2011 with Peter Morrow, a former colleague from Golden Gate Capital. Sycamore specializes in retail and consumer investments and has grown to roughly $10 billion in aggregate committed capital (reported by some sources at more than $13 billion in assets), making Kaluzny one of the most active — and controversial — dealmakers in American retail. As of mid-2026, Forbes estimated his net worth at approximately $1.3 billion. He is 59 and resides in New York.

Before founding Sycamore, Kaluzny spent roughly a decade (2000–January 2011) as a Managing Partner at Golden Gate Capital, joining at the firm's inception and working across software, semiconductors, consumer products, and retailing. Earlier in his career he co-founded Delray Farms, Inc., a fresh-grocery chain serving Hispanic communities in the Chicago area, where he also served as CEO. He began his career in management consulting at Bain & Company and L.E.K.

Kaluzny holds a BA from Yale University and an MBA from Harvard Business School. He has served as a director or chairman across a large roster of Sycamore portfolio and public companies, including Chairman of Torrid Holdings (since 2021) and director roles at Staples, Talbots, Hot Topic, Stuart Weitzman, Orchard Brands, Belk, and — following Sycamore's 2025 take-private — Walgreens Boots Alliance. He is also a Trustee of Phillips Academy (Andover) and involved with Friends of the High Line and Robert F. Kennedy Human Rights.

Kaluzny keeps a notably low public profile. Sycamore's own team page lists him only by name and title ("Founder, Managing Director") with no biography, consistent with his reputation as a press-shy operator.

• Control-oriented retail/consumer buyouts, not venture or seed investing — Sycamore takes majority/whole-company positions in established brands.
• Targets distressed, underperforming, or complex carve-out situations where value can be unlocked through restructuring, cost cutting, real-estate monetization, and separation of business units.
• Deploys leveraged buyout, special-situations, and distressed strategies across apparel, specialty retail, office supply, home goods, and drugstore retail.
• Frequently breaks up acquired companies into standalone units to monetize parts (e.g., splitting Walgreens into Walgreens, Boots, Shields Health, CareCentrix, and VillageMD).
• Raises large dedicated funds: Fund I (~$1B, 2012), Fund II (~$2.5B, 2014), Fund III ($4.75B, 2018).
• On Walgreens, Kaluzny framed the rationale around the retailer's community role: WBA and its companies "play an essential role in the communities they serve around the world."